Active home-based cancer treatment
Authors:
- Paolo TralongoPTPaolo Tralongo
- Dimari AnnaDADimari Anna
- Fabrizio RomanoFRFabrizio Romano
- Pumo VitalindaPVPumo Vitalinda
- Rametta Giuliano SebastianoRSRametta Giuliano Sebastiano
- Margherita IaconoMIMargherita Iacono
- Eleonora LanteriELEleonora Lanteri
- Elena PuzzoEPElena Puzzo
- Sebastiano SpadaSSSebastiano Spada
Open Access
- 1 June 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. 5, 137-143
Abstract
Background: Active home-based treatment represents a new model of health care. Chronic treatment requires continuous access to facilities that provide cancer care, with considerable effort, particularly economic, on the part of patients and caregivers. Oral chemotherapy could be limited as a consequence of poor compliance and adherence, especially by elderly patients. Methods: We selected 30 cancer patients referred to our department and treated with oral therapy (capecitabine, vinorelbine, imatinib, sunitinib, sorafenib, temozolomide, ibandronate). This pilot study of oral therapy in the patient’s home was undertaken by a doctor and two nurses with experience in clinical oncology. The instruments used were clinical diaries recording home visits, hospital visits, need for caregiver support, and a questionnaire specially developed by the European Organization for Research and Treatment of Cancer (EORTC), known as the QLQ-C30 version 2.0, concerning the acceptability of oral treatment from the patient’s perspective. Results: This program decreased the need to access cancer facilities by 98.1%, promoted better quality of life for patients, as reflected in increased EORTC QLQ-C30 scores over time, allowing for greater adherence to oral treatment as a result of control of drug administration outside the hospital. This model has allowed treatment of patients with difficult access to care (elderly, disabled or otherwise needed caregivers) that in the project represent the majority (78% of these). Conclusions: This model of active home care improves quality of life and adherence with oral therapy, reduces the need to visit the hospital, and consequently decreases the number of lost hours of work on the part of carers. Management of the service by the professionals involved revealed excellent control of the process by nursing staff, with minimal visits involving doctors.Keywords
This publication has 24 references indexed in Scilit:
- Challenges of Oral Medications in Patients With Advanced Breast CancerSeminars in Oncology Nursing, 2007
- Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein CholesterolJAMA, 2006
- Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancerAnnals of Oncology, 2005
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Patient preferences for oral versus intravenous palliative chemotherapy.Journal of Clinical Oncology, 1997
- Treatment compliance in childhood and adolescenceCancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Symptoms Associated With Tamoxifen Treatment in Postmenopausal WomenArchives of internal medicine (1960), 1991